Fig. 4From: Clinical characteristics of renal transplant recipients who developed de novo donor-specific antigen in Kyoto University Hospital: a case seriesA Tacrolimus troughs over the immediate past year prior to DSA detection. B Comparison of tacrolimus troughs over the immediate past year prior to DSA detection. DSA: donor-specific antigen; mTOR: mammalian target of rapamycin; CNI: calcineurin inhibitorBack to article page